Mallya UG, Boklage SH, Koren A, Delea TE, Mullins CD. Budget impact analysis of PCSK9 inhibitors for the management of adult patients with heterozygous familial hypercholesterolemia or clinical atherosclerotic cardiovascular disease. Pharmacoeconomics 2018;36(1):115-26. - PAI - Policy Analysis Inc.

Mallya UG, Boklage SH, Koren A, Delea TE, Mullins CD. Budget impact analysis of PCSK9 inhibitors for the management of adult patients with heterozygous familial hypercholesterolemia or clinical atherosclerotic cardiovascular disease. Pharmacoeconomics 2018;36(1):115-26. - PAI - Policy Analysis Inc.